Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients

Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.

Reuters May 29, 2020 16:47:10 IST
Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients

Bengaluru: Drugmaker Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreatitis drug nafamostat mesilate in COVID-19 patients.

"Nafamostat (has been) identified as a potential candidate for COVID-19 patients by scientists at University of Tokyo and Leibniz Institute for Primate Research, Germany," the company said in a statement.

Click here to follow LIVE updates on coronavirus outbreak

The University of Tokyo had announced plans for a trial of nafamostat and camostat mesilate, a related drug, starting as early as April 2020.

Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.

Updated Date:

also read

Vaccinating teachers, students for board exams should've begun in January; offline exams risky now, says IWPA president
India

Vaccinating teachers, students for board exams should've begun in January; offline exams risky now, says IWPA president

Anubha Shrivastava Sahai, lawyer and president of the India Wide Parents Association, on the risks of holding board exams, and possible alternatives

Over 780 mn COVID-19 vaccine shots administered globally, but pandemic far from over, says WHO chief
World

Over 780 mn COVID-19 vaccine shots administered globally, but pandemic far from over, says WHO chief

Tedros Adhanom Ghebreyesus voiced concern that confusion, complacency and inconsistency in public health measures and their application are driving transmission and costing lives

Crisis looms over Kolkata hospitals amid shortage of COVID-19 beds, spike in cases
India

Crisis looms over Kolkata hospitals amid shortage of COVID-19 beds, spike in cases

Bengal on Monday registered 4,511 fresh COVID-19 cases, the highest single-day spike since the onset of the pandemic last year